About Us

Mission

Our mission is to connect, exchange and educate.

  • Connect:  Bring together a broad audience including policy makers  (government, regulators), funders (health foundations, charities), the academic research community (universities, research and knowledge institutes), environmental and human toxicity, industries (pharmaceutical, chemical, food, cosmetics and other industries), medical centers and practitioners, patient associations,  and service/testing centers from all over the world. It will allow communication between different stakeholders as well as interaction between young scientists and senior experts in the MPS field, which will not only promote international standardization and harmonization of MPS, but also establish a global training environment.
  • Exchange: Facilitate collaborative environment; learning from each other about challenges and opportunities. Implement global cooperative efforts to advance MPS development, promote this technology and accelerate acceptance by regulators and end users. This is needed to maximize its potential to advance the life sciences, from basic to clinical research, from drug screening to safety assessment.
  • Educate: The mission is not only education of a new generation of scientist, but also established scientists entering the field, and regulators to allow the rapid, safe and responsible adoption of this technology.

Vision

Our vision is to accelerate the use of MPS to improve health, welfare, and the environment.

The vision is achieved through:

  • Research (strengthen the society as the hub for MPS research and increase its impact)
  • Education (empower current and future society members with the knowledge and resources needed in biomedical research)
  • Community (cultivate a diverse, inclusive and engaged community by increasing access and opportunities for interaction)
  • Increase awareness and understanding of the utility of MPS in biomedical research, its impact on health, environment and economy, and emphasize the need for funding

Core Values

  • Excellence and Integrity
  • Diversity, Equity and Inclusion
  • Innovation and Impact
  • Respect and Accountability
  • Connection and Collaboration
  • Education and Career Development
with shadow

Board of Directors

James-Hickman-400x400-2

President

James Hickman
Hesperos, Inc. (USA)

Jan-Lichtenberg-400x400-2

President-Elect

Jan Lichtenberg
InSphero (Switzerland)

Jan Lichtenberg

Past President

Lena Smirnova
Johns Hopkins University, (USA)

Magdalena-Kasendra-1-1

Secretary

Magdalena Kasendra
Children’s Hospital of Cincinnati (USA)

Seiichi-Ishida

Treasurer

Seiichi Ishida
NIHS (Japan)

Elizabeth Baker
Elizabeth Baker

Dynavet Solutions (USA)

Zaozao Chen
Zaozao Chen

Columbia University (USA)

Lorna Ewart
Lorna Ewart

Emulate, Inc. (USA)

Suzanne Fitzpatrick
Suzanne Fitzpatrick

Food and Drug Administration (USA)

Chrisna Gouws
Chrisna Gouws

North-West University (South Africa)

Nicholas-Geisse-400x400
Nicholas Geisse

Curi Bio (USA)

zhonge-gu-400x400
Zhongze Gu

Southeast University (China)

Nina Hobi
Nina Hobi

AlveoliX (EU)

Noo Li Jeon
Noo Li Jeon

Seoul National University
(South Korea)

Roger Kamm
Roger Kamm

Massachusetts Institute of Technology (USA)

peter-loskill-400x400
Peter Loskill

University of Tübingen (Germany)

Annie-Moisan-400x400
Annie Moisan

Roche Pharma Research & Early Development (pRED) (Switzerland)

Milica Radisic
Milica Radisic

University of Toronto (Canada)

Staff portraits of NCATS personnel for internal directory.
*Dan Tagle

NIH (USA)

Michael Shuler
Michael Shuler

Cornell University (USA)

Evita van Steeg
Evita van Steeg

TNO (Netherlands)

Joseph Wu
Joseph Wu

Stanford University (USA)

*non-voting member